Atossa Therapeutics, INC. (ATOS) SEC Filings — 2024

Filings

• Atossa Therapeutics Files 8-K with Financials — 8-K · Dec 10, 2024
• Atossa Therapeutics Enters Material Definitive Agreement — 8-K · Nov 19, 2024
• Atossa Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
• Atossa Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Atossa Therapeutics, INC. SC 13G Filing — SC 13G · Nov 8, 2024
• Atossa Therapeutics Files 8-K — 8-K · Nov 4, 2024
• Atossa Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• Atossa Therapeutics, INC. SC 13G Filing — SC 13G · Oct 22, 2024
• Atossa Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
• Atossa Therapeutics Files 8-K: Director Changes & Officer Compensation Updates — 8-K · Jul 2, 2024
• Atossa Therapeutics Files Definitive Proxy Statement — DEF 14A · May 23, 2024
• Atossa Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Atossa Therapeutics Files 8-K/A Amendment — 8-K/A · Apr 2, 2024
• Atossa Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
• Atossa Therapeutics Faces Delisting, Plans Reverse Stock Split — 8-K · Mar 18, 2024
• Atossa Therapeutics Files 8-K with Board and Compensation Updates — 8-K · Mar 12, 2024